(E,3R,5S)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid,
itavastatin,
itavastatin calcium,
nisvastatin,
NK 104,
NK-104,
P 872441,
P-872441,
pitavastatin,
pitavastatin calcium,
pitavastatin lactone,
Pitavastatin calcium,
147526-32-7,
Livalo,
Pitavastatin hemicalcium,
NK-104,
UNII-IYD54XEG3W,
Flovas,
IYD54XEG3W,
Nisvastatin,
2C25H23FNO4.Ca,
Calcium (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate,
CHEBI:71258,
NK 104 (acid),
Itavastatin calcium,
Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt,
Pitavastatin calcium (JAN),
Alipza,
Livazo,
147511-69-1,
P 872441,
P-872441,
(+)-monocalciumbis{(3r,5s,6e)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-hepten,
6-Heptenoic acid, 7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl)-3,5-dihydroxy-, calcium salt (2:1), (S-(R*,S*-(E)))-,
calcium (E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate,
Pitavastatin calcium salt,
Redevant,
CCRIS 8652,
AK-50694,
Livalo (TN),
AC1NR03G,
SCHEMBL22720,
CHEMBL1237061,
DTXSID4046448,
CHEBI:94569,
NKS-104,
RHGYHLPFVJEAOC-FFNUKLMVSA-L,
ACT02718,
calcium;(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate,
2299AH,
MFCD01937979,
AKOS015900407,
AM84441,
AN-6862,
AT-3425,
KS-1220,
111GE002,
BC654789,
BR-50694,
LS-74595,
SC-18906,
AB2000276,
ST24030237,
D01862,
Q-201590,
(+)-MONOCALCIUMBIS[(3R,5S,6E)-7-[2-CYCLOPROPYL-4(4-FLUOROPHENYL)-3-QUINOLYL]3,5-DIHYDROXY-6-HEPTENO ATE],
(3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid hemicalcium salt,
6-Heptenoic acid, 7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl)-3,5-dihydroxy-,calcium salt (2:1), (3R,5S,6E)-,
6-Heptenoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E)-,
Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate) monocalcium salt,
calcium (E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-hept-6-enoate,
calcium(2+) bis((3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate),
Pitavastatin,
Itavastatin,
Vezepra,
Pitavastatin [INN],
Pitavastatin calcium?,
D0H9WN,
NK 104,
UNII-M5681Q5F9P,
C25H24FNO4,
C25H24FNO4.1/2Ca,
C25-H24-F-N-O4,
ACN-048271,
CID5282451,
CS-O-30720,
C25-H24-F-N-O4.1/2Ca,
Pitavastatin calcium, 99% - 10MG 10mg,
A10737,
( )-(3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoic acid,
(+) Monocalcium bis [(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoate],
(+)- Monocalcium bis [(3R,5S,6E)-7-[2-cyclopropyl-4-(4- fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoate],
(3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid,
(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid,
10031-30-8,
calcium bis{(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate},